SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 134 filers reported holding SANGAMO THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.23 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $4,000 | -20.0% | 730 | 0.0% | 0.00% | -50.0% |
| Q4 2021 | $5,000 | -28.6% | 730 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $7,000 | -22.2% | 730 | 0.0% | 0.00% | -33.3% |
| Q2 2021 | $9,000 | 0.0% | 730 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $9,000 | -18.2% | 730 | 0.0% | 0.00% | -40.0% |
| Q4 2020 | $11,000 | +83.3% | 730 | +12.3% | 0.01% | +66.7% |
| Q3 2020 | $6,000 | 0.0% | 650 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $6,000 | -91.2% | 650 | -93.9% | 0.00% | -93.3% |
| Q1 2020 | $68,000 | +1260.0% | 10,650 | +1538.5% | 0.04% | +1400.0% |
| Q4 2019 | $5,000 | -16.7% | 650 | 0.0% | 0.00% | -25.0% |
| Q3 2019 | $6,000 | -14.3% | 650 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $7,000 | +16.7% | 650 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $6,000 | -14.3% | 650 | 0.0% | 0.00% | -20.0% |
| Q4 2018 | $7,000 | -22.2% | 650 | 0.0% | 0.01% | -16.7% |
| Q3 2018 | $9,000 | 0.0% | 650 | 0.0% | 0.01% | -14.3% |
| Q2 2018 | $9,000 | -25.0% | 650 | 0.0% | 0.01% | -22.2% |
| Q1 2018 | $12,000 | – | 650 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FIC CAPITAL INC | 875,284 | $2,670,000 | 1.34% |
| NEXTHERA CAPITAL LP | 503,000 | $1,534,000 | 0.90% |
| Opaleye Management Inc. | 400,000 | $1,220,000 | 0.72% |
| WASATCH ADVISORS LP | 7,256,260 | $22,132,000 | 0.33% |
| Cormorant Asset Management, LP | 650,000 | $1,983,000 | 0.27% |
| Sicart Associates LLC | 101,950 | $311,000 | 0.22% |
| Baker Brothers Advisors | 4,055,876 | $12,370,000 | 0.12% |
| Leisure Capital Management | 43,008 | $131,000 | 0.12% |
| Piermont Capital Management Inc. | 165,569 | $505,000 | 0.12% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 837,963 | $2,556,000 | 0.10% |